IgG subclasses determine pathways of anaphylaxis in mice

Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and IgG2b bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1 binds only FcγRIII and FcγRIIB. Although thes...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 139; no. 1; pp. 269 - 280.e7
Main Authors Beutier, Héloïse, PharmD, Gillis, Caitlin M., BSci, Iannascoli, Bruno, BTS, Godon, Ophélie, MSc, England, Patrick, PhD, Sibilano, Riccardo, PhD, Reber, Laurent L., PhD, Galli, Stephen J., MD, Cragg, Mark S., PhD, Van Rooijen, Nico, PhD, Mancardi, David A., PhD, Bruhns, Pierre, PhD, Jönsson, Friederike, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2017
Elsevier Limited
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and IgG2b bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1 binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis. Objective We sought to determine which pathways control the induction of IgG1 -, IgG2a -, and IgG2b -dependent passive systemic anaphylaxis. Methods Mice were sensitized with IgG1 , IgG2a , or IgG2b anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis. Results Activating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1 - and IgG2b -induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis. Conclusion We propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass–dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
AbstractList Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG and IgG bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis. We sought to determine which pathways control the induction of IgG -, IgG -, and IgG -dependent passive systemic anaphylaxis. Mice were sensitized with IgG , IgG , or IgG anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis. Activating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG - and IgG -induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis. We propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass-dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
BACKGROUND:Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and IgG2b bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1 binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis.OBJECTIVE:We sought to determine which pathways control the induction of IgG1-, IgG2a-, and IgG2b-dependent passive systemic anaphylaxis.METHODS:Mice were sensitized with IgG1, IgG2a, or IgG2b anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis.RESULTS:Activating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1- and IgG2b-induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis.CONCLUSION:We propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass-dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (Fc gamma Rs). Mouse IgG2a and IgG2b bind activating Fc gamma RI, Fc gamma RIII, and Fc gamma RIV and inhibitory Fc gamma RIIB; mouse IgG1 binds only Fc gamma RIII and Fc gamma RIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis. Objective We sought to determine which pathways control the induction of IgG1-, IgG2a-, and IgG2b-dependent passive systemic anaphylaxis. Methods Mice were sensitized with IgG1, IgG2a, or IgG2b anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for Fc gamma Rs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. Fc gamma R expression was evaluated on these cells before and after anaphylaxis. Results Activating Fc gamma RIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1- and IgG2b-induced anaphylaxis correlated with the ability of inhibitory Fc gamma RIIB to negatively regulate these models of anaphylaxis. Conclusion We propose that the differential expression of inhibitory Fc gamma RIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass-dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and IgG2b bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1 binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis. Objective We sought to determine which pathways control the induction of IgG1 -, IgG2a -, and IgG2b -dependent passive systemic anaphylaxis. Methods Mice were sensitized with IgG1 , IgG2a , or IgG2b anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis. Results Activating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1 - and IgG2b -induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis. Conclusion We propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass–dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
BACKGROUNDAnimal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and IgG2b bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1 binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis.OBJECTIVEWe sought to determine which pathways control the induction of IgG1-, IgG2a-, and IgG2b-dependent passive systemic anaphylaxis.METHODSMice were sensitized with IgG1, IgG2a, or IgG2b anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis.RESULTSActivating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1- and IgG2b-induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis.CONCLUSIONWe propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass-dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and IgG2b bind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1 binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis. We sought to determine which pathways control the induction of IgG1-, IgG2a-, and IgG2b-dependent passive systemic anaphylaxis. Mice were sensitized with IgG1, IgG2a, or IgG2b anti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis. Activating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1- and IgG2b-induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis. We propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass–dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactions in vivo.
Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2aand IgG2bbind activating FcγRI, FcγRIII, and FcγRIV and inhibitory FcγRIIB; mouse IgG1binds only FcγRIII and FcγRIIB. Although these interactions are of strikingly different affinities, these 3 IgG subclasses have been shown to enable induction of systemic anaphylaxis. Objective We sought to determine which pathways control the induction of IgG1-, IgG2a-, and IgG2b-dependent passive systemic anaphylaxis. Methods Mice were sensitized with IgG1, IgG2a, or IgG2banti-trinitrophenyl mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was monitored by using rectal temperature. Anaphylaxis was evaluated in mice deficient for FcγRs injected with mediator antagonists or in which basophils, monocytes/macrophages, or neutrophils had been depleted. FcγR expression was evaluated on these cells before and after anaphylaxis. Results Activating FcγRIII is the receptor primarily responsible for all 3 models of anaphylaxis, and subsequent downregulation of this receptor was observed. These models differentially relied on histamine release and the contribution of mast cells, basophils, macrophages, and neutrophils. Strikingly, basophil contribution and histamine predominance in mice with IgG1- and IgG2b-induced anaphylaxis correlated with the ability of inhibitory FcγRIIB to negatively regulate these models of anaphylaxis. Conclusion We propose that the differential expression of inhibitory FcγRIIB on myeloid cells and its differential binding of IgG subclasses controls the contributions of mast cells, basophils, neutrophils, and macrophages to IgG subclass-dependent anaphylaxis. Collectively, our results unravel novel complexities in the involvement and regulation of cell populations in IgG-dependent reactionsin vivo.
Author Gillis, Caitlin M., BSci
Beutier, Héloïse, PharmD
Iannascoli, Bruno, BTS
Bruhns, Pierre, PhD
Van Rooijen, Nico, PhD
England, Patrick, PhD
Jönsson, Friederike, PhD
Galli, Stephen J., MD
Mancardi, David A., PhD
Reber, Laurent L., PhD
Godon, Ophélie, MSc
Sibilano, Riccardo, PhD
Cragg, Mark S., PhD
AuthorAffiliation 3 Université Pierre et Marie Curie, Paris, France
8 Department of Molecular Cell Biology, VU Medical Center, Amsterdam, The Netherlands
1 Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France
5 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
7 Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK
2 INSERM, U1222, Paris, France
6 Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA, USA
4 Institut Pasteur, Plate-Forme de Biophysique Moléculaire, Centre d'Innovation et Recherche Technologique (CiTech), CNRS-UMR3528, Paris, France
AuthorAffiliation_xml – name: 3 Université Pierre et Marie Curie, Paris, France
– name: 4 Institut Pasteur, Plate-Forme de Biophysique Moléculaire, Centre d'Innovation et Recherche Technologique (CiTech), CNRS-UMR3528, Paris, France
– name: 6 Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA, USA
– name: 2 INSERM, U1222, Paris, France
– name: 8 Department of Molecular Cell Biology, VU Medical Center, Amsterdam, The Netherlands
– name: 5 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
– name: 1 Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France
– name: 7 Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK
Author_xml – sequence: 1
  fullname: Beutier, Héloïse, PharmD
– sequence: 2
  fullname: Gillis, Caitlin M., BSci
– sequence: 3
  fullname: Iannascoli, Bruno, BTS
– sequence: 4
  fullname: Godon, Ophélie, MSc
– sequence: 5
  fullname: England, Patrick, PhD
– sequence: 6
  fullname: Sibilano, Riccardo, PhD
– sequence: 7
  fullname: Reber, Laurent L., PhD
– sequence: 8
  fullname: Galli, Stephen J., MD
– sequence: 9
  fullname: Cragg, Mark S., PhD
– sequence: 10
  fullname: Van Rooijen, Nico, PhD
– sequence: 11
  fullname: Mancardi, David A., PhD
– sequence: 12
  fullname: Bruhns, Pierre, PhD
– sequence: 13
  fullname: Jönsson, Friederike, PhD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27246523$$D View this record in MEDLINE/PubMed
https://pasteur.hal.science/pasteur-01388338$$DView record in HAL
BookMark eNqNkk1v1DAQhi1URLeFP8ABReLCJWFsJ44toUpVRT-klTgAZ8txJl0vWWexk4X993W0pcAeECfbmmfeGc87Z-TEDx4JeU2hoEDF-3WxNtYVLN0L4AUw-YwsKKg6F5JVJ2QBoGgu6lKdkrMY15DeXKoX5JTVrBQV4wsi7-5vsjg1tjcxYsxaHDFsnMdsa8bVD7OP2dBlxpvtat-bny5mzmcbZ_Eled6ZPuKrx_OcfL3--OXqNl9-urm7ulzmVoAac1RVo6gQlQVuwUpblry1BmSnGhSqRqMamaK2hapsy7IuhW2okKi6TiJX_JxcHHS3U7PB1qIfg-n1NriNCXs9GKf_jni30vfDTlcgKZMsCeQHgdVR2u3lUm9NHHEKGiiXknO5o4l_91gwDN8njKPeuGix743HYYqaykqVqqql-A-UCaGAMUjo2yN0PUzBp8nNgpKK1Opcmx0oG4YYA3ZPDVPQs-d6rWfP9ey5Bq6T5ynpzZ8Tekr5ZXICPhwATD7tHAYdrUNvsXUB7ajbwf1b_-Io3fbOO2v6b7jH-PsfOjIN-vO8dfPSUcGBVhL4A97E0p4
CitedBy_id crossref_primary_10_3389_fimmu_2019_00190
crossref_primary_10_1007_s11882_021_00988_y
crossref_primary_10_4168_aard_2022_10_4_195
crossref_primary_10_1016_j_gpb_2019_05_002
crossref_primary_10_1136_jitc_2022_005657
crossref_primary_10_1111_all_15738
crossref_primary_10_1111_obr_13621
crossref_primary_10_1016_j_jaci_2018_09_027
crossref_primary_10_4049_jimmunol_2200234
crossref_primary_10_3389_fimmu_2018_01027
crossref_primary_10_3390_vaccines10010133
crossref_primary_10_1016_j_bbrc_2017_12_099
crossref_primary_10_1016_j_jaci_2021_01_009
crossref_primary_10_1208_s12248_020_00461_0
crossref_primary_10_1016_j_jaci_2017_06_003
crossref_primary_10_3389_fimmu_2020_00118
crossref_primary_10_1007_s11095_018_2448_8
crossref_primary_10_3389_fimmu_2020_575936
crossref_primary_10_1111_imm_13081
crossref_primary_10_3389_fimmu_2019_03130
crossref_primary_10_3390_biology12121501
crossref_primary_10_1016_j_jaci_2024_05_012
crossref_primary_10_1016_j_jaip_2019_10_048
crossref_primary_10_3389_falgy_2022_1092262
crossref_primary_10_1038_s41598_021_01395_z
crossref_primary_10_4049_jimmunol_2000149
crossref_primary_10_1016_j_jprot_2022_104809
crossref_primary_10_1172_JCI126275
crossref_primary_10_1016_j_jaci_2021_02_013
crossref_primary_10_1016_j_jaci_2020_05_056
crossref_primary_10_1016_j_reval_2018_03_003
crossref_primary_10_1186_s12865_020_00376_7
crossref_primary_10_3390_ijms22094935
crossref_primary_10_1016_j_jaci_2017_06_012
crossref_primary_10_1016_j_jaci_2022_10_014
crossref_primary_10_1126_scitranslmed_aat1479
crossref_primary_10_1007_s11882_018_0819_1
crossref_primary_10_1080_08820139_2022_2130799
crossref_primary_10_1146_annurev_immunol_071719_094903
crossref_primary_10_3390_vaccines10060969
crossref_primary_10_3389_fimmu_2018_00958
crossref_primary_10_3390_ijms23158234
crossref_primary_10_1016_j_nutres_2017_09_009
crossref_primary_10_3389_fimmu_2018_01244
crossref_primary_10_1016_j_jaci_2017_10_042
crossref_primary_10_3389_fimmu_2017_01193
crossref_primary_10_3390_ijms20194964
crossref_primary_10_1016_j_alit_2017_04_007
crossref_primary_10_1016_j_isci_2021_103131
crossref_primary_10_1097_ACI_0000000000000363
crossref_primary_10_1016_j_jaci_2017_06_021
crossref_primary_10_1016_j_jaci_2022_01_014
crossref_primary_10_1002_eji_202350454
crossref_primary_10_1007_s11882_016_0658_x
crossref_primary_10_2174_1389203723666220620164024
crossref_primary_10_3389_fimmu_2017_00515
crossref_primary_10_3390_cells8060546
crossref_primary_10_1016_j_jaci_2017_03_045
crossref_primary_10_1002_iid3_288
crossref_primary_10_1177_1753425920981133
crossref_primary_10_1051_medsci_20183404015
crossref_primary_10_1016_j_jaci_2016_06_058
crossref_primary_10_1128_spectrum_01674_22
crossref_primary_10_3389_fphar_2023_1211332
Cites_doi 10.1172/JCI45232
10.1016/j.jaci.2013.06.008
10.4049/jimmunol.170.5.2549
10.1126/science.1118948
10.1038/nri2762
10.1073/pnas.1105695108
10.1189/jlb.1212623
10.1111/j.1365-2567.2007.02588.x
10.1038/nri3582
10.1172/JCI36452
10.1182/blood-2011-03-343962
10.1038/nri2155
10.1067/mai.2002.125977
10.1016/j.jaci.2013.09.008
10.1016/j.immuni.2005.05.010
10.1084/jem.142.6.1520
10.1016/j.immuni.2008.02.008
10.1016/0022-1759(94)90012-4
10.1159/000229815
10.1182/blood-2008-09-179754
10.1016/j.immuni.2011.11.009
10.1016/j.jaci.2009.11.017
10.3389/fimmu.2012.00016
10.1016/S0014-2999(97)01142-4
10.4049/jimmunol.160.1.20
10.1172/JCI119255
10.4049/jimmunol.1200968
10.1002/eji.201142302
10.1182/blood-2015-09-671339
10.1016/j.jaci.2013.06.015
10.1016/S0952-7915(00)00154-0
10.1016/j.imlet.2012.01.002
10.1002/eji.200939884
10.4049/jimmunol.0902752
10.1016/j.coi.2005.09.012
10.1067/mai.2002.123302
10.1016/j.jaci.2004.12.1125
10.1084/jem.189.10.1573
10.1073/pnas.1014515107
10.1182/blood-2012-07-442541
10.1182/blood-2011-07-367334
10.1182/blood-2012-01-380121
10.1074/jbc.M400808200
10.4049/jimmunol.1003642
10.1016/j.cellimm.2014.03.018
10.1016/j.immuni.2010.08.011
ContentType Journal Article
Copyright American Academy of Allergy, Asthma & Immunology
2016 American Academy of Allergy, Asthma & Immunology
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Jan 01, 2017
Copyright
Copyright_xml – notice: American Academy of Allergy, Asthma & Immunology
– notice: 2016 American Academy of Allergy, Asthma & Immunology
– notice: Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Jan 01, 2017
– notice: Copyright
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7SS
7T5
H94
K9.
NAPCQ
7X8
1XC
VOOES
5PM
DOI 10.1016/j.jaci.2016.03.028
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

AIDS and Cancer Research Abstracts

MEDLINE - Academic

Entomology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 280.e7
ExternalDocumentID oai_HAL_pasteur_01388338v1
4300731221
10_1016_j_jaci_2016_03_028
27246523
S0091674916301580
1_s2_0_S0091674916301580
Genre Journal Article
GeographicLocations California
GeographicLocations_xml – name: California
GrantInformation_xml – fundername: NIAMS
  grantid: R01 AR067145
  funderid: http://dx.doi.org/10.13039/100000069
– fundername: NIH
  funderid: http://dx.doi.org/10.13039/100000002
– fundername: Institut Carnot Pasteur Maladies Infectieuses
– fundername: Institut Pasteur
  funderid: http://dx.doi.org/10.13039/501100003762
– fundername: Department of Pathology at Stanford University
– fundername: Société Française d'Allergologie
– fundername: Balsan company
– fundername: Institut National de la Santé et de la Recherche Médicale
  funderid: http://dx.doi.org/10.13039/501100001677
– fundername: NIAMS NIH HHS
  grantid: R01 AR067145
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
3V.
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
7RV
7X7
8C1
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFO
ACGFS
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
ADVLN
AEBSH
AEKER
AENEX
AFFNX
AFJKZ
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BBNVY
BENPR
BHPHI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HCIFZ
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M2O
M41
M7P
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
CITATION
7SS
7T5
H94
K9.
NAPCQ
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c609t-e95b91665c03c0c8c443dca08f9be697ea9b865ccd054d44746cb168e9ff8e393
IEDL.DBID AIKHN
ISSN 0091-6749
IngestDate Tue Sep 17 21:16:42 EDT 2024
Tue Oct 15 15:32:58 EDT 2024
Fri Oct 25 21:11:31 EDT 2024
Thu Oct 24 22:46:25 EDT 2024
Thu Oct 10 18:04:28 EDT 2024
Fri Dec 06 01:05:23 EST 2024
Wed Oct 16 00:57:53 EDT 2024
Fri Feb 23 02:34:42 EST 2024
Tue Oct 15 22:55:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Fluorescein isothiocyanate
Mast cell protease 1
Association rate
histamine
RU
Gfi1
IgG
Neonatal IgG receptor
platelet-activating factor
basophil
neutrophil
mMCP-1
Growth factor independence 1
FITC
Anaphylaxis
TNP
FcRn
C57Bl/6 wild-type
Dissociation equilibrium constant
Trinitrophenyl
TRIM21
WT
PSA
Tripartite motif-containing protein 21
mouse model
Affinity constant
macrophage
Resonance units
K off
IgG Fc receptor
K A
K D
PAF
K on
Passive systemic anaphylaxis
monocyte
Dissociation rate
FcγR
KA
KD
Koff
Kon
Language English
License Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Copyright: http://hal.archives-ouvertes.fr/licences/copyright
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c609t-e95b91665c03c0c8c443dca08f9be697ea9b865ccd054d44746cb168e9ff8e393
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
co-senior authorship.
ORCID 0000-0002-4709-8936
0000-0003-3384-6769
0000-0002-1667-8065
0000-0001-6410-5918
0000-0003-1511-3764
OpenAccessLink https://pasteur.hal.science/pasteur-01388338
PMID 27246523
PQID 1858162821
PQPubID 105664
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5081282
hal_primary_oai_HAL_pasteur_01388338v1
proquest_miscellaneous_1859495786
proquest_miscellaneous_1826690220
proquest_journals_1858162821
crossref_primary_10_1016_j_jaci_2016_03_028
pubmed_primary_27246523
elsevier_sciencedirect_doi_10_1016_j_jaci_2016_03_028
elsevier_clinicalkeyesjournals_1_s2_0_S0091674916301580
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2017
Publisher Elsevier Inc
Elsevier Limited
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
– name: Elsevier
References Nimmerjahn, Ravetch (bib13) 2005; 310
Mancardi, Iannascoli, Hoos, England, Daeron, Bruhns (bib16) 2008; 118
Jonsson, Mancardi, Albanesi, Bruhns (bib3) 2013; 94
Makabe-Kobayashi, Hori, Adachi, Ishigaki-Suzuki, Kikuchi, Kagaya (bib35) 2002; 110
Ujike, Ishikawa, Ono, Yuasa, Yoshino, Fukumoto (bib19) 1999; 189
Smith, Clatworthy (bib46) 2010; 10
Jönsson, Mancardi, Kita, Karasuyama, Iannascoli, Van Rooijen (bib18) 2011; 121
Yucel, Kosan, Heyd, Moroy (bib30) 2004; 279
Tsujimura, Obata, Mukai, Shindou, Yoshida, Nishikado (bib20) 2008; 28
Saylor, Dadachova, Casadevall (bib12) 2010; 184
Jiao, Liu, Lu, Liu, Pan, Liu (bib28) 2014; 289
Veri, Gorlatov, Li, Burke, Johnson, Stavenhagen (bib47) 2007; 121
Williams, Tutt, French, Chan, Lau, Penfold (bib27) 2012; 42
Khodoun, Strait, Armstrong, Yanase, Finkelman (bib31) 2011; 108
Bruhns, Fremont, Daëron (bib10) 2005; 17
Unkeless, Eisen (bib15) 1975; 142
Reber, Marichal, Mukai, Kita, Tokuoka, Roers (bib36) 2013; 132
Van Rooijen, Sanders (bib26) 1994; 174
Stone, Prussin, Metcalfe (bib43) 2010; 125
Guilliams, Bruhns, Saeys, Hammad, Lambrecht (bib8) 2014; 14
Gavin, Barnes, Dijstelbloem, Hogarth (bib11) 1998; 160
Wedemeyer, Tsai, Galli (bib38) 2000; 12
Nimmerjahn, Bruhns, Horiuchi, Ravetch (bib14) 2005; 23
Khodoun, Kucuk, Strait, Krishnamurthy, Janek, Clay (bib5) 2013; 132
Roopenian, Akilesh (bib9) 2007; 7
Bruhns, Iannascoli, England, Mancardi, Fernandez, Jorieux (bib48) 2009; 113
Miyajima, Dombrowicz, Martin, Ravetch, Kinet, Galli (bib17) 1997; 99
Finkelman, Rothenberg, Brandt, Morris, Strait (bib2) 2005; 115
Ohnmacht, Schwartz, Panzer, Schiedewitz, Naumann, Voehringer (bib45) 2010; 33
Jonsson, Daeron (bib39) 2012; 3
Strait, Morris, Yang, Qu, Finkelman (bib22) 2002; 109
Biburger, Nimmerjahn (bib29) 2012; 143
Syed, Konrad, Wiege, Nieswandt, Nimmerjahn, Schmidt (bib41) 2009; 39
Biburger, Aschermann, Schwab, Lux, Albert, Danzer (bib34) 2011; 35
Nimmerjahn, Lux, Albert, Woigk, Lehmann, Dudziak (bib42) 2010; 107
Bruhns (bib7) 2012; 119
Camussi, Aglietta, Coda, Bussolino, Piacibello, Tetta (bib37) 1981; 42
Iff, Vaz (bib4) 1966; 30
Brown, Stone, Fatovich, Burrows, Holdgate, Celenza (bib1) 2013; 132
Cassard, Jonsson, Arnaud, Daeron (bib21) 2012; 189
Tan, Gavin, Barnes, Sears, Vremec, Shortman (bib32) 2003; 170
Mancardi, Albanesi, Jonsson, Iannascoli, Van Rooijen, Kang (bib24) 2013; 121
Jonsson, Mancardi, Zhao, Kita, Iannascoli, Khun (bib23) 2012; 119
Mancardi, Jonsson, Iannascoli, Khun, Van Rooijen, Huerre (bib33) 2011; 186
Tipton, Mockridge, French, Tutt, Cragg, Beers (bib40) 2015; 126
Lilla, Chen, Mukai, BenBarak, Franco, Kalesnikoff (bib25) 2011; 118
Million, Fioramonti, Zajac, Bueno (bib6) 1997; 334
Capron (bib44) 1989; 19
18949059 - J Clin Invest. 2008 Nov;118(11):3738-50
15252036 - J Biol Chem. 2004 Sep 24;279(39):40906-17
23915716 - J Allergy Clin Immunol. 2013 Oct;132(4):881-8.e1-11
20414206 - Nat Rev Immunol. 2010 May;10(5):328-43
6161885 - Immunology. 1981 Feb;42(2):191-9
12170272 - J Allergy Clin Immunol. 2002 Aug;110(2):298-303
17386079 - Immunology. 2007 Jul;121(3):392-404
1194857 - J Exp Med. 1975 Dec 1;142(6):1520-33
16322460 - Science. 2005 Dec 2;310(5753):1510-2
8083541 - J Immunol Methods. 1994 Sep 14;174(1-2):83-93
9346330 - Eur J Pharmacol. 1997 Sep 3;334(1):67-73
22169040 - Immunity. 2011 Dec 23;35(6):932-44
22535666 - Blood. 2012 Jun 14;119(24):5640-9
22566901 - Front Immunol. 2012 Feb 20;3:16
9062348 - J Clin Invest. 1997 Mar 1;99(5):901-14
26492935 - Blood. 2015 Dec 10;126(24):2643-5
19949107 - J Immunol. 2010 Jan 1;184(1):336-43
12594281 - J Immunol. 2003 Mar 1;170(5):2549-56
19795417 - Eur J Immunol. 2009 Dec;39(12):3343-56
11941316 - J Allergy Clin Immunol. 2002 Apr;109(4):658-68
19018092 - Blood. 2009 Apr 16;113(16):3716-25
24445665 - Nat Rev Immunol. 2014 Feb;14(2):94-108
2713741 - Clin Exp Allergy. 1989 Jan;19 Suppl 1:3-8
21248252 - J Immunol. 2011 Feb 15;186(4):1899-903
21436586 - J Clin Invest. 2011 Apr;121(4):1484-96
22285694 - Immunol Lett. 2012 Mar 30;143(1):53-9
16039578 - Immunity. 2005 Jul;23(1):41-51
10330436 - J Exp Med. 1999 May 17;189(10):1573-9
17703228 - Nat Rev Immunol. 2007 Sep;7(9):715-25
23532517 - J Leukoc Biol. 2013 Oct;94(4):643-56
21746933 - Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12413-8
11102764 - Curr Opin Immunol. 2000 Dec;12(6):624-31
20974962 - Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19396-401
15753886 - J Allergy Clin Immunol. 2005 Mar;115(3):449-57; quiz 458
22908332 - J Immunol. 2012 Sep 15;189(6):2995-3006
24139828 - J Allergy Clin Immunol. 2013 Dec;132(6):1375-87
16214316 - Curr Opin Immunol. 2005 Dec;17(6):662-9
22138510 - Blood. 2012 Mar 15;119(11):2533-44
23915715 - J Allergy Clin Immunol. 2013 Nov;132(5):1141-1149.e5
20817571 - Immunity. 2010 Sep 24;33(3):364-74
23293080 - Blood. 2013 Feb 28;121(9):1563-73
20176269 - J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S73-80
5927729 - Int Arch Allergy Appl Immunol. 1966;30(4):313-22
18342553 - Immunity. 2008 Apr;28(4):581-9
22001390 - Blood. 2011 Dec 22;118(26):6930-8
24751884 - Cell Immunol. 2014 May-Jun;289(1-2):97-105
22760702 - Eur J Immunol. 2012 Aug;42(8):2109-20
9551950 - J Immunol. 1998 Jan 1;160(1):20-3
Yucel (10.1016/j.jaci.2016.03.028_bib30) 2004; 279
Tipton (10.1016/j.jaci.2016.03.028_bib40) 2015; 126
Stone (10.1016/j.jaci.2016.03.028_bib43) 2010; 125
Khodoun (10.1016/j.jaci.2016.03.028_bib5) 2013; 132
Miyajima (10.1016/j.jaci.2016.03.028_bib17) 1997; 99
Ujike (10.1016/j.jaci.2016.03.028_bib19) 1999; 189
Tsujimura (10.1016/j.jaci.2016.03.028_bib20) 2008; 28
Nimmerjahn (10.1016/j.jaci.2016.03.028_bib13) 2005; 310
Ohnmacht (10.1016/j.jaci.2016.03.028_bib45) 2010; 33
Roopenian (10.1016/j.jaci.2016.03.028_bib9) 2007; 7
Nimmerjahn (10.1016/j.jaci.2016.03.028_bib42) 2010; 107
Mancardi (10.1016/j.jaci.2016.03.028_bib16) 2008; 118
Wedemeyer (10.1016/j.jaci.2016.03.028_bib38) 2000; 12
Jonsson (10.1016/j.jaci.2016.03.028_bib3) 2013; 94
Strait (10.1016/j.jaci.2016.03.028_bib22) 2002; 109
Mancardi (10.1016/j.jaci.2016.03.028_bib33) 2011; 186
Bruhns (10.1016/j.jaci.2016.03.028_bib48) 2009; 113
Capron (10.1016/j.jaci.2016.03.028_bib44) 1989; 19
Finkelman (10.1016/j.jaci.2016.03.028_bib2) 2005; 115
Mancardi (10.1016/j.jaci.2016.03.028_bib24) 2013; 121
Smith (10.1016/j.jaci.2016.03.028_bib46) 2010; 10
Veri (10.1016/j.jaci.2016.03.028_bib47) 2007; 121
Unkeless (10.1016/j.jaci.2016.03.028_bib15) 1975; 142
Bruhns (10.1016/j.jaci.2016.03.028_bib10) 2005; 17
Jiao (10.1016/j.jaci.2016.03.028_bib28) 2014; 289
Cassard (10.1016/j.jaci.2016.03.028_bib21) 2012; 189
Jonsson (10.1016/j.jaci.2016.03.028_bib39) 2012; 3
Iff (10.1016/j.jaci.2016.03.028_bib4) 1966; 30
Bruhns (10.1016/j.jaci.2016.03.028_bib7) 2012; 119
Makabe-Kobayashi (10.1016/j.jaci.2016.03.028_bib35) 2002; 110
Guilliams (10.1016/j.jaci.2016.03.028_bib8) 2014; 14
Lilla (10.1016/j.jaci.2016.03.028_bib25) 2011; 118
Gavin (10.1016/j.jaci.2016.03.028_bib11) 1998; 160
Syed (10.1016/j.jaci.2016.03.028_bib41) 2009; 39
Reber (10.1016/j.jaci.2016.03.028_bib36) 2013; 132
Van Rooijen (10.1016/j.jaci.2016.03.028_bib26) 1994; 174
Million (10.1016/j.jaci.2016.03.028_bib6) 1997; 334
Saylor (10.1016/j.jaci.2016.03.028_bib12) 2010; 184
Khodoun (10.1016/j.jaci.2016.03.028_bib31) 2011; 108
Biburger (10.1016/j.jaci.2016.03.028_bib34) 2011; 35
Jönsson (10.1016/j.jaci.2016.03.028_bib18) 2011; 121
Biburger (10.1016/j.jaci.2016.03.028_bib29) 2012; 143
Brown (10.1016/j.jaci.2016.03.028_bib1) 2013; 132
Camussi (10.1016/j.jaci.2016.03.028_bib37) 1981; 42
Nimmerjahn (10.1016/j.jaci.2016.03.028_bib14) 2005; 23
Jonsson (10.1016/j.jaci.2016.03.028_bib23) 2012; 119
Williams (10.1016/j.jaci.2016.03.028_bib27) 2012; 42
Tan (10.1016/j.jaci.2016.03.028_bib32) 2003; 170
References_xml – volume: 132
  start-page: 1375
  year: 2013
  end-page: 1387
  ident: bib5
  article-title: Rapid desensitization of mice with anti-FcgammaRIIb/FcgammaRIII mAb safely prevents IgG-mediated anaphylaxis
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Clay
– volume: 99
  start-page: 901
  year: 1997
  end-page: 914
  ident: bib17
  article-title: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis
  publication-title: J Clin Invest
  contributor:
    fullname: Galli
– volume: 174
  start-page: 83
  year: 1994
  end-page: 93
  ident: bib26
  article-title: Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications
  publication-title: J Immunol Methods
  contributor:
    fullname: Sanders
– volume: 310
  start-page: 1510
  year: 2005
  end-page: 1512
  ident: bib13
  article-title: Divergent immunoglobulin g subclass activity through selective Fc receptor binding
  publication-title: Science
  contributor:
    fullname: Ravetch
– volume: 170
  start-page: 2549
  year: 2003
  end-page: 2556
  ident: bib32
  article-title: Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells
  publication-title: J Immunol
  contributor:
    fullname: Shortman
– volume: 113
  start-page: 3716
  year: 2009
  end-page: 3725
  ident: bib48
  article-title: Specificity and affinity of human Fc{gamma} receptors and their polymorphic variants for human IgG subclasses
  publication-title: Blood
  contributor:
    fullname: Jorieux
– volume: 142
  start-page: 1520
  year: 1975
  end-page: 1533
  ident: bib15
  article-title: Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages
  publication-title: J Exp Med
  contributor:
    fullname: Eisen
– volume: 42
  start-page: 191
  year: 1981
  end-page: 199
  ident: bib37
  article-title: Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils
  publication-title: Immunology
  contributor:
    fullname: Tetta
– volume: 126
  start-page: 2643
  year: 2015
  end-page: 2645
  ident: bib40
  article-title: Anti-mouse FcgammaRIV antibody 9E9 also blocks FcgammaRIII in vivo
  publication-title: Blood
  contributor:
    fullname: Beers
– volume: 110
  start-page: 298
  year: 2002
  end-page: 303
  ident: bib35
  article-title: The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Kagaya
– volume: 184
  start-page: 336
  year: 2010
  end-page: 343
  ident: bib12
  article-title: Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of
  publication-title: J Immunol
  contributor:
    fullname: Casadevall
– volume: 125
  start-page: S73
  year: 2010
  end-page: S80
  ident: bib43
  article-title: IgE, mast cells, basophils, and eosinophils
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Metcalfe
– volume: 143
  start-page: 53
  year: 2012
  end-page: 59
  ident: bib29
  article-title: Low level of FcgammaRIII expression on murine natural killer cells
  publication-title: Immunol Lett
  contributor:
    fullname: Nimmerjahn
– volume: 160
  start-page: 20
  year: 1998
  end-page: 23
  ident: bib11
  article-title: Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity
  publication-title: J Immunol
  contributor:
    fullname: Hogarth
– volume: 189
  start-page: 2995
  year: 2012
  end-page: 3006
  ident: bib21
  article-title: Fcgamma receptors inhibit mouse and human basophil activation
  publication-title: J Immunol
  contributor:
    fullname: Daeron
– volume: 94
  start-page: 643
  year: 2013
  end-page: 656
  ident: bib3
  article-title: Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions
  publication-title: J Leukoc Biol
  contributor:
    fullname: Bruhns
– volume: 334
  start-page: 67
  year: 1997
  end-page: 73
  ident: bib6
  article-title: Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Bueno
– volume: 119
  start-page: 5640
  year: 2012
  end-page: 5649
  ident: bib7
  article-title: Properties of mouse and human IgG receptors and their contribution to disease models
  publication-title: Blood
  contributor:
    fullname: Bruhns
– volume: 33
  start-page: 364
  year: 2010
  end-page: 374
  ident: bib45
  article-title: Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths
  publication-title: Immunity
  contributor:
    fullname: Voehringer
– volume: 118
  start-page: 6930
  year: 2011
  end-page: 6938
  ident: bib25
  article-title: Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice
  publication-title: Blood
  contributor:
    fullname: Kalesnikoff
– volume: 115
  start-page: 449
  year: 2005
  end-page: 458
  ident: bib2
  article-title: Molecular mechanisms of anaphylaxis: lessons from studies with murine models
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Strait
– volume: 289
  start-page: 97
  year: 2014
  end-page: 105
  ident: bib28
  article-title: Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice
  publication-title: Cell Immunol
  contributor:
    fullname: Liu
– volume: 279
  start-page: 40906
  year: 2004
  end-page: 40917
  ident: bib30
  article-title: Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development
  publication-title: J Biol Chem
  contributor:
    fullname: Moroy
– volume: 107
  start-page: 19396
  year: 2010
  end-page: 19401
  ident: bib42
  article-title: FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Dudziak
– volume: 121
  start-page: 1484
  year: 2011
  end-page: 1496
  ident: bib18
  article-title: Mouse and human neutrophils induce anaphylaxis
  publication-title: J Clin Invest
  contributor:
    fullname: Van Rooijen
– volume: 10
  start-page: 328
  year: 2010
  end-page: 343
  ident: bib46
  article-title: FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications
  publication-title: Nat Rev Immunol
  contributor:
    fullname: Clatworthy
– volume: 23
  start-page: 41
  year: 2005
  end-page: 51
  ident: bib14
  article-title: Fc gamma RIV: a novel FcR with distinct IgG subclass specificity
  publication-title: Immunity
  contributor:
    fullname: Ravetch
– volume: 17
  start-page: 662
  year: 2005
  end-page: 669
  ident: bib10
  article-title: Regulation of allergy by Fc receptors
  publication-title: Curr Opin Immunol
  contributor:
    fullname: Daëron
– volume: 118
  start-page: 3738
  year: 2008
  end-page: 3750
  ident: bib16
  article-title: FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation
  publication-title: J Clin Invest
  contributor:
    fullname: Bruhns
– volume: 121
  start-page: 1563
  year: 2013
  end-page: 1573
  ident: bib24
  article-title: The high-affinity human IgG receptor FcgammaRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy
  publication-title: Blood
  contributor:
    fullname: Kang
– volume: 39
  start-page: 3343
  year: 2009
  end-page: 3356
  ident: bib41
  article-title: Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a
  publication-title: Eur J Immunol
  contributor:
    fullname: Schmidt
– volume: 42
  start-page: 2109
  year: 2012
  end-page: 2120
  ident: bib27
  article-title: Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcgammaRIIB (CD32B)
  publication-title: Eur J Immunol
  contributor:
    fullname: Penfold
– volume: 30
  start-page: 313
  year: 1966
  end-page: 322
  ident: bib4
  article-title: Mechanisms of anaphylaxis in the mouse. Similarity of shock induced by anaphylaxis and by mixtures of histamine and serotonin
  publication-title: Int Arch Allergy Appl Immunol
  contributor:
    fullname: Vaz
– volume: 132
  start-page: 881
  year: 2013
  end-page: 888.e11
  ident: bib36
  article-title: Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Roers
– volume: 119
  start-page: 2533
  year: 2012
  end-page: 2544
  ident: bib23
  article-title: Human FcgammaRIIA induces anaphylactic and allergic reactions
  publication-title: Blood
  contributor:
    fullname: Khun
– volume: 35
  start-page: 932
  year: 2011
  end-page: 944
  ident: bib34
  article-title: Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo
  publication-title: Immunity
  contributor:
    fullname: Danzer
– volume: 109
  start-page: 658
  year: 2002
  end-page: 668
  ident: bib22
  article-title: Pathways of anaphylaxis in the mouse
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Finkelman
– volume: 12
  start-page: 624
  year: 2000
  end-page: 631
  ident: bib38
  article-title: Roles of mast cells and basophils in innate and acquired immunity
  publication-title: Curr Opin Immunol
  contributor:
    fullname: Galli
– volume: 121
  start-page: 392
  year: 2007
  end-page: 404
  ident: bib47
  article-title: Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization
  publication-title: Immunology
  contributor:
    fullname: Stavenhagen
– volume: 14
  start-page: 94
  year: 2014
  end-page: 108
  ident: bib8
  article-title: The function of Fcgamma receptors in dendritic cells and macrophages
  publication-title: Nat Rev Immunol
  contributor:
    fullname: Lambrecht
– volume: 19
  start-page: 3
  year: 1989
  end-page: 8
  ident: bib44
  article-title: Eosinophils: receptors and mediators in hypersensitivity
  publication-title: Clin Exp Allergy
  contributor:
    fullname: Capron
– volume: 108
  start-page: 12413
  year: 2011
  end-page: 12418
  ident: bib31
  article-title: Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Finkelman
– volume: 7
  start-page: 715
  year: 2007
  end-page: 725
  ident: bib9
  article-title: FcRn: the neonatal Fc receptor comes of age
  publication-title: Nat Rev Immunol
  contributor:
    fullname: Akilesh
– volume: 28
  start-page: 581
  year: 2008
  end-page: 589
  ident: bib20
  article-title: Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis
  publication-title: Immunity
  contributor:
    fullname: Nishikado
– volume: 3
  start-page: 16
  year: 2012
  ident: bib39
  article-title: Mast cells and company
  publication-title: Front Immunol
  contributor:
    fullname: Daeron
– volume: 132
  start-page: 1141
  year: 2013
  end-page: 1149.e5
  ident: bib1
  article-title: Anaphylaxis: clinical patterns, mediator release, and severity
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Celenza
– volume: 186
  start-page: 1899
  year: 2011
  end-page: 1903
  ident: bib33
  article-title: The murine high-affinity IgG receptor Fc(gamma)RIV is sufficient for autoantibody-induced arthritis
  publication-title: J Immunol
  contributor:
    fullname: Huerre
– volume: 189
  start-page: 1573
  year: 1999
  end-page: 1579
  ident: bib19
  article-title: Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG
  publication-title: J Exp Med
  contributor:
    fullname: Fukumoto
– volume: 121
  start-page: 1484
  year: 2011
  ident: 10.1016/j.jaci.2016.03.028_bib18
  article-title: Mouse and human neutrophils induce anaphylaxis
  publication-title: J Clin Invest
  doi: 10.1172/JCI45232
  contributor:
    fullname: Jönsson
– volume: 132
  start-page: 881
  year: 2013
  ident: 10.1016/j.jaci.2016.03.028_bib36
  article-title: Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.06.008
  contributor:
    fullname: Reber
– volume: 170
  start-page: 2549
  year: 2003
  ident: 10.1016/j.jaci.2016.03.028_bib32
  article-title: Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.5.2549
  contributor:
    fullname: Tan
– volume: 310
  start-page: 1510
  year: 2005
  ident: 10.1016/j.jaci.2016.03.028_bib13
  article-title: Divergent immunoglobulin g subclass activity through selective Fc receptor binding
  publication-title: Science
  doi: 10.1126/science.1118948
  contributor:
    fullname: Nimmerjahn
– volume: 10
  start-page: 328
  year: 2010
  ident: 10.1016/j.jaci.2016.03.028_bib46
  article-title: FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2762
  contributor:
    fullname: Smith
– volume: 19
  start-page: 3
  issue: suppl 1
  year: 1989
  ident: 10.1016/j.jaci.2016.03.028_bib44
  article-title: Eosinophils: receptors and mediators in hypersensitivity
  publication-title: Clin Exp Allergy
  contributor:
    fullname: Capron
– volume: 108
  start-page: 12413
  year: 2011
  ident: 10.1016/j.jaci.2016.03.028_bib31
  article-title: Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1105695108
  contributor:
    fullname: Khodoun
– volume: 94
  start-page: 643
  year: 2013
  ident: 10.1016/j.jaci.2016.03.028_bib3
  article-title: Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.1212623
  contributor:
    fullname: Jonsson
– volume: 121
  start-page: 392
  year: 2007
  ident: 10.1016/j.jaci.2016.03.028_bib47
  article-title: Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2007.02588.x
  contributor:
    fullname: Veri
– volume: 14
  start-page: 94
  year: 2014
  ident: 10.1016/j.jaci.2016.03.028_bib8
  article-title: The function of Fcgamma receptors in dendritic cells and macrophages
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3582
  contributor:
    fullname: Guilliams
– volume: 118
  start-page: 3738
  year: 2008
  ident: 10.1016/j.jaci.2016.03.028_bib16
  article-title: FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation
  publication-title: J Clin Invest
  doi: 10.1172/JCI36452
  contributor:
    fullname: Mancardi
– volume: 118
  start-page: 6930
  year: 2011
  ident: 10.1016/j.jaci.2016.03.028_bib25
  article-title: Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice
  publication-title: Blood
  doi: 10.1182/blood-2011-03-343962
  contributor:
    fullname: Lilla
– volume: 7
  start-page: 715
  year: 2007
  ident: 10.1016/j.jaci.2016.03.028_bib9
  article-title: FcRn: the neonatal Fc receptor comes of age
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2155
  contributor:
    fullname: Roopenian
– volume: 110
  start-page: 298
  year: 2002
  ident: 10.1016/j.jaci.2016.03.028_bib35
  article-title: The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2002.125977
  contributor:
    fullname: Makabe-Kobayashi
– volume: 132
  start-page: 1375
  year: 2013
  ident: 10.1016/j.jaci.2016.03.028_bib5
  article-title: Rapid desensitization of mice with anti-FcgammaRIIb/FcgammaRIII mAb safely prevents IgG-mediated anaphylaxis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.09.008
  contributor:
    fullname: Khodoun
– volume: 23
  start-page: 41
  year: 2005
  ident: 10.1016/j.jaci.2016.03.028_bib14
  article-title: Fc gamma RIV: a novel FcR with distinct IgG subclass specificity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.05.010
  contributor:
    fullname: Nimmerjahn
– volume: 142
  start-page: 1520
  year: 1975
  ident: 10.1016/j.jaci.2016.03.028_bib15
  article-title: Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages
  publication-title: J Exp Med
  doi: 10.1084/jem.142.6.1520
  contributor:
    fullname: Unkeless
– volume: 28
  start-page: 581
  year: 2008
  ident: 10.1016/j.jaci.2016.03.028_bib20
  article-title: Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.02.008
  contributor:
    fullname: Tsujimura
– volume: 174
  start-page: 83
  year: 1994
  ident: 10.1016/j.jaci.2016.03.028_bib26
  article-title: Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications
  publication-title: J Immunol Methods
  doi: 10.1016/0022-1759(94)90012-4
  contributor:
    fullname: Van Rooijen
– volume: 30
  start-page: 313
  year: 1966
  ident: 10.1016/j.jaci.2016.03.028_bib4
  article-title: Mechanisms of anaphylaxis in the mouse. Similarity of shock induced by anaphylaxis and by mixtures of histamine and serotonin
  publication-title: Int Arch Allergy Appl Immunol
  doi: 10.1159/000229815
  contributor:
    fullname: Iff
– volume: 113
  start-page: 3716
  year: 2009
  ident: 10.1016/j.jaci.2016.03.028_bib48
  article-title: Specificity and affinity of human Fc{gamma} receptors and their polymorphic variants for human IgG subclasses
  publication-title: Blood
  doi: 10.1182/blood-2008-09-179754
  contributor:
    fullname: Bruhns
– volume: 35
  start-page: 932
  year: 2011
  ident: 10.1016/j.jaci.2016.03.028_bib34
  article-title: Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo
  publication-title: Immunity
  doi: 10.1016/j.immuni.2011.11.009
  contributor:
    fullname: Biburger
– volume: 125
  start-page: S73
  year: 2010
  ident: 10.1016/j.jaci.2016.03.028_bib43
  article-title: IgE, mast cells, basophils, and eosinophils
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2009.11.017
  contributor:
    fullname: Stone
– volume: 42
  start-page: 191
  year: 1981
  ident: 10.1016/j.jaci.2016.03.028_bib37
  article-title: Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils
  publication-title: Immunology
  contributor:
    fullname: Camussi
– volume: 3
  start-page: 16
  year: 2012
  ident: 10.1016/j.jaci.2016.03.028_bib39
  article-title: Mast cells and company
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2012.00016
  contributor:
    fullname: Jonsson
– volume: 334
  start-page: 67
  year: 1997
  ident: 10.1016/j.jaci.2016.03.028_bib6
  article-title: Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(97)01142-4
  contributor:
    fullname: Million
– volume: 160
  start-page: 20
  year: 1998
  ident: 10.1016/j.jaci.2016.03.028_bib11
  article-title: Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.1.20
  contributor:
    fullname: Gavin
– volume: 99
  start-page: 901
  year: 1997
  ident: 10.1016/j.jaci.2016.03.028_bib17
  article-title: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis
  publication-title: J Clin Invest
  doi: 10.1172/JCI119255
  contributor:
    fullname: Miyajima
– volume: 189
  start-page: 2995
  year: 2012
  ident: 10.1016/j.jaci.2016.03.028_bib21
  article-title: Fcgamma receptors inhibit mouse and human basophil activation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1200968
  contributor:
    fullname: Cassard
– volume: 42
  start-page: 2109
  year: 2012
  ident: 10.1016/j.jaci.2016.03.028_bib27
  article-title: Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcgammaRIIB (CD32B)
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201142302
  contributor:
    fullname: Williams
– volume: 126
  start-page: 2643
  year: 2015
  ident: 10.1016/j.jaci.2016.03.028_bib40
  article-title: Anti-mouse FcgammaRIV antibody 9E9 also blocks FcgammaRIII in vivo
  publication-title: Blood
  doi: 10.1182/blood-2015-09-671339
  contributor:
    fullname: Tipton
– volume: 132
  start-page: 1141
  year: 2013
  ident: 10.1016/j.jaci.2016.03.028_bib1
  article-title: Anaphylaxis: clinical patterns, mediator release, and severity
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.06.015
  contributor:
    fullname: Brown
– volume: 12
  start-page: 624
  year: 2000
  ident: 10.1016/j.jaci.2016.03.028_bib38
  article-title: Roles of mast cells and basophils in innate and acquired immunity
  publication-title: Curr Opin Immunol
  doi: 10.1016/S0952-7915(00)00154-0
  contributor:
    fullname: Wedemeyer
– volume: 143
  start-page: 53
  year: 2012
  ident: 10.1016/j.jaci.2016.03.028_bib29
  article-title: Low level of FcgammaRIII expression on murine natural killer cells
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2012.01.002
  contributor:
    fullname: Biburger
– volume: 39
  start-page: 3343
  year: 2009
  ident: 10.1016/j.jaci.2016.03.028_bib41
  article-title: Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200939884
  contributor:
    fullname: Syed
– volume: 184
  start-page: 336
  year: 2010
  ident: 10.1016/j.jaci.2016.03.028_bib12
  article-title: Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0902752
  contributor:
    fullname: Saylor
– volume: 17
  start-page: 662
  year: 2005
  ident: 10.1016/j.jaci.2016.03.028_bib10
  article-title: Regulation of allergy by Fc receptors
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2005.09.012
  contributor:
    fullname: Bruhns
– volume: 109
  start-page: 658
  year: 2002
  ident: 10.1016/j.jaci.2016.03.028_bib22
  article-title: Pathways of anaphylaxis in the mouse
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2002.123302
  contributor:
    fullname: Strait
– volume: 115
  start-page: 449
  year: 2005
  ident: 10.1016/j.jaci.2016.03.028_bib2
  article-title: Molecular mechanisms of anaphylaxis: lessons from studies with murine models
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2004.12.1125
  contributor:
    fullname: Finkelman
– volume: 189
  start-page: 1573
  year: 1999
  ident: 10.1016/j.jaci.2016.03.028_bib19
  article-title: Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG
  publication-title: J Exp Med
  doi: 10.1084/jem.189.10.1573
  contributor:
    fullname: Ujike
– volume: 107
  start-page: 19396
  year: 2010
  ident: 10.1016/j.jaci.2016.03.028_bib42
  article-title: FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1014515107
  contributor:
    fullname: Nimmerjahn
– volume: 121
  start-page: 1563
  year: 2013
  ident: 10.1016/j.jaci.2016.03.028_bib24
  article-title: The high-affinity human IgG receptor FcgammaRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy
  publication-title: Blood
  doi: 10.1182/blood-2012-07-442541
  contributor:
    fullname: Mancardi
– volume: 119
  start-page: 2533
  year: 2012
  ident: 10.1016/j.jaci.2016.03.028_bib23
  article-title: Human FcgammaRIIA induces anaphylactic and allergic reactions
  publication-title: Blood
  doi: 10.1182/blood-2011-07-367334
  contributor:
    fullname: Jonsson
– volume: 119
  start-page: 5640
  year: 2012
  ident: 10.1016/j.jaci.2016.03.028_bib7
  article-title: Properties of mouse and human IgG receptors and their contribution to disease models
  publication-title: Blood
  doi: 10.1182/blood-2012-01-380121
  contributor:
    fullname: Bruhns
– volume: 279
  start-page: 40906
  year: 2004
  ident: 10.1016/j.jaci.2016.03.028_bib30
  article-title: Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M400808200
  contributor:
    fullname: Yucel
– volume: 186
  start-page: 1899
  year: 2011
  ident: 10.1016/j.jaci.2016.03.028_bib33
  article-title: The murine high-affinity IgG receptor Fc(gamma)RIV is sufficient for autoantibody-induced arthritis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1003642
  contributor:
    fullname: Mancardi
– volume: 289
  start-page: 97
  year: 2014
  ident: 10.1016/j.jaci.2016.03.028_bib28
  article-title: Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2014.03.018
  contributor:
    fullname: Jiao
– volume: 33
  start-page: 364
  year: 2010
  ident: 10.1016/j.jaci.2016.03.028_bib45
  article-title: Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.08.011
  contributor:
    fullname: Ohnmacht
SSID ssj0009389
Score 2.5209267
Snippet Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs)....
Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG2a and...
Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse IgG and...
BACKGROUNDAnimal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs). Mouse...
Background Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (Fc gamma...
BACKGROUND:Animal models have demonstrated that allergen-specific IgG confers sensitivity to systemic anaphylaxis that relies on IgG Fc receptors (FcγRs)....
SourceID pubmedcentral
hal
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 269
SubjectTerms Allergies
Allergy and Immunology
Anaphylaxis
Anaphylaxis - immunology
Animals
Antibodies, Monoclonal - immunology
basophil
Colleges & universities
Female
Haptens - immunology
histamine
Histamine - immunology
Human subjects
IgG
IgG Fc receptor
Immunoglobulin E - immunology
Immunoglobulin G - immunology
Immunoglobulins
Immunology
Life Sciences
macrophage
Mice, Inbred C57BL
Mice, Transgenic
monocyte
mouse model
Myeloid Cells - immunology
neutrophil
Neutrophils
platelet-activating factor
Protein Subunits - immunology
Receptors, IgG - genetics
Receptors, IgG - immunology
Rodents
Serum Albumin, Bovine - immunology
Title IgG subclasses determine pathways of anaphylaxis in mice
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0091674916301580
https://dx.doi.org/10.1016/j.jaci.2016.03.028
https://www.ncbi.nlm.nih.gov/pubmed/27246523
https://www.proquest.com/docview/1858162821
https://search.proquest.com/docview/1826690220
https://search.proquest.com/docview/1859495786
https://pasteur.hal.science/pasteur-01388338
https://pubmed.ncbi.nlm.nih.gov/PMC5081282
Volume 139
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELb6kBAXVN6hpTIS4oJCk_gR-7iqWrZAe6JSb5btODRVlV01u7Rc-O2d2ThblqIeuOQQO8ros2f8jT0zJuQ9c0o4nanUeuZSXoYytWAgQd2BTajasdzi1sDxiRyf8i9n4myN7A-5MBhWGW1_b9MX1jq-2Yto7k2bBnN8NYbQwwMmqVDgt2_CcoRntZujo6_jk7vau0z1LFjnKX4Qc2f6MK8L6xuM8JKLWqd4Kfu_16f1cwyUvM9C_w6m_GN1OtwiTyKtpKNe8qdkLbTPyKPjeHD-nKijH59pN3ceyXLoaBWjYALFK4mv7a-OTmpqW6xefWlvmo42LcWb6l-Q08OD7_vjNF6akHqZ6VkaNGCfSyl8xnzmleecVd5mqtYuSF0Gq52CVl8BWas4L7n0Lpcq6LpWgWn2kmy0kza8JlRrrqBHcHXOuPOVkwW33klw0ZyoyiwhHweozLSvjWGGoLELg8AaBNZkzACwCSkHNM2Q9Ql2KnRRaTqTm64wmbk3sAkRyy9X5oYBs__gHz_AoC1Fw0La49E3M7WgP_Mrg2e0Cjz0n3lCdoZxNXfSKKFyCR4pNL9bNoPy4YmKbcNkjn2A32hMVn6oj9DghZZKJuRVP1WWIhVlwaUoGGCzMolWZF5taZvzRRFwINZALYo3_4nNNnlcIEFZbCbtkI3Z1Ty8BXo1c7tk_dPvfDcq0S0E6CKq
link.rule.ids 230,314,780,784,885,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4k2ggJEQFxSaxI_Yx6qibGG3p1bqzbIdh6ZC2VWzy-PCb2cmcbYsRT1wySF2lNHnmck38cyYkDfMKeF0plLrmUt5GcrUgoMEcwc2oWrHcou_BmZHcnLCP52K0y2yP9bCYFpl9P2DT--9dbyzG9HcXTQN1vhqTKGHCyipUBC33-QC2C8o9ftfl3kemqmBA-s8xemxcmZI8jq3vsH8Ltl3OsUj2f_9dbpxhmmSVzno36mUf3ybDu6Ru5FU0r1B7vtkK7QPyK1Z3DZ_SNThl4-0WzmPVDl0tIo5MIHigcTf7c-OzmtqW-xd_dX-aDratBTPqX9ETg4-HO9P0nhkQuplppdp0IB8LqXwGfOZV55zVnmbqVq7IHUZrHYKRn0FVK3ivOTSu1yqoOtaBabZY7LdztvwlFCtuYIZwdU5485XThbceichQHOiKrOEvBuhMouhM4YZU8bODQJrEFiTMQPAJqQc0TRjzSd4qdBFk-lMbrrCZObKsiZErJ_c0AwDTv_aN76FRVuLhm20J3tTs7BgPasLgzu0CuLzb3lCdsZ1NZfSKKFyCfEoDL9eD4Pp4X6KbcN8hXOA3WgsVb5ujtAQg5ZKJuTJoCprkYqy4FIUDLDZUKINmTdH2uasbwEOtBqIRfHsP7F5RW5PjmdTMz08-vyc3CmQqvS_lXbI9vJiFV4A0Vq6l70h_QatByOD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IgG+subclasses+determine+pathways+of+anaphylaxis+in+mice&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Beutier%2C+H%C3%A9lo%C3%AFse&rft.au=Gillis%2C+Caitlin+M&rft.au=Iannascoli%2C+Bruno&rft.au=Godon%2C+Oph%C3%A9lie&rft.date=2017-01-01&rft.eissn=1097-6825&rft.volume=139&rft.issue=1&rft.spage=269&rft_id=info:doi/10.1016%2Fj.jaci.2016.03.028&rft_id=info%3Apmid%2F27246523&rft.externalDocID=27246523
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon